From: The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
Model | Analysis | Outcome | Variable | Estimate ± SE | P-value |
---|---|---|---|---|---|
Model A | I | CSF ptau | Age | −0.32 ± 0.2 | 0.05 |
Sex | −2.41 ± 2.3 | 0.29 | |||
CDR-SB | 3.35 ± 0.6 | 7.25 × 10−8 | |||
C3 | 6.10 ± 6.5 | 0.35 | |||
II | CSF ptau | Age | −0.22 ± 0.1 | 0.14 | |
Sex | −1.15 ± 2.05 | 0.58 | |||
CDR-SB | 1.67 ± 0.6 | 5.01 × 10−3 | |||
C3 | 12.11 ± 5.9 | 0.04 | |||
CSF amyloid | −0.14 ± 0.02 | 4.97 × 10−12 | |||
Model B | I | CSF ptau | Age | −0.25 ± 0.15 | 0.10 |
Sex | −1.11 ± 2.1 | 0.59 | |||
CDR-SB | 1.70 ± 0.6 | 4.47 × 10−3 | |||
C3 | 27.7 ± 19.6 | 0.16 | |||
CSF amyloid | −0.38 ± 0.3 | 0.19 | |||
C3:CSF amyloid | −0.09 ± 0.1 | 0.41 |